Artwork

Sisällön tarjoaa Kyle Gillett and James O'Hara, Kyle Gillett, and James O'Hara. Kyle Gillett and James O'Hara, Kyle Gillett, and James O'Hara tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
Player FM - Podcast-sovellus
Siirry offline-tilaan Player FM avulla!

MDMA For PTSD? | The Gillett Health Podcast #87

30:29
 
Jaa
 

Manage episode 435022619 series 3425668
Sisällön tarjoaa Kyle Gillett and James O'Hara, Kyle Gillett, and James O'Hara. Kyle Gillett and James O'Hara, Kyle Gillett, and James O'Hara tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.

Dr. Gillett & James O'Hara discuss the FDA ruling on MDMA.

00:00 Intro

01:10 FDA's decision on MDMA therapy is pending, with possibilities ranging from approval.

06:00 MDMA affects various hormones post-consumption, including serotonin and cortisol, potentially impacting mood and physiology.

09:30 MDMA trials for PTSD

14:55 Concerns over MDMA trials

21:32 FDA critiques MDMA therapy training protocols for therapists to prevent abuse.

24:33 MDMA is considered safer compared to benzodiazepines in certain respects.

27:33 Balancing drug accessibility and safety through regulatory measures is crucial to advancing scientific research and ensuring public health.

29:30 Outro

Studies/References:

https://sci-hub.se/https://pubmed.ncbi.nlm.nih.gov/31734398/

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205851/

https://www.nature.com/articles/s41591-023-02565-4

https://abcnews.go.com/Health/fda-advisers-recommending-mdma-treatment-ptsd/story?id=110808948

For High-Quality Labs:

https://gilletthealth.com/order-lab-panels/

For information on the Gillett Health clinic, lab panels, and health coaching:

https://GillettHealth.com

Follow Gillett Health for more content from James and Kyle

https://instagram.com/gilletthealth

https://www.tiktok.com/@gilletthealth

https://twitter.com/gilletthealth

https://www.facebook.com/gilletthealth

Follow Kyle Gillett, MD

https://instagram.com/kylegillettmd

Follow James O’Hara, NP

https://Instagram.com/jamesoharanp

For 10% off Gorilla Mind products including SIGMA: Use code “GH10”

https://gorillamind.com/

For discounts on high-quality supplements

►https://www.thorne.com/u/GillettHealth

#ptsd #fda #podcast


Advertising Inquiries: https://redcircle.com/brands
Privacy & Opt-Out: https://redcircle.com/privacy
  continue reading

115 jaksoa

Artwork
iconJaa
 
Manage episode 435022619 series 3425668
Sisällön tarjoaa Kyle Gillett and James O'Hara, Kyle Gillett, and James O'Hara. Kyle Gillett and James O'Hara, Kyle Gillett, and James O'Hara tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.

Dr. Gillett & James O'Hara discuss the FDA ruling on MDMA.

00:00 Intro

01:10 FDA's decision on MDMA therapy is pending, with possibilities ranging from approval.

06:00 MDMA affects various hormones post-consumption, including serotonin and cortisol, potentially impacting mood and physiology.

09:30 MDMA trials for PTSD

14:55 Concerns over MDMA trials

21:32 FDA critiques MDMA therapy training protocols for therapists to prevent abuse.

24:33 MDMA is considered safer compared to benzodiazepines in certain respects.

27:33 Balancing drug accessibility and safety through regulatory measures is crucial to advancing scientific research and ensuring public health.

29:30 Outro

Studies/References:

https://sci-hub.se/https://pubmed.ncbi.nlm.nih.gov/31734398/

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205851/

https://www.nature.com/articles/s41591-023-02565-4

https://abcnews.go.com/Health/fda-advisers-recommending-mdma-treatment-ptsd/story?id=110808948

For High-Quality Labs:

https://gilletthealth.com/order-lab-panels/

For information on the Gillett Health clinic, lab panels, and health coaching:

https://GillettHealth.com

Follow Gillett Health for more content from James and Kyle

https://instagram.com/gilletthealth

https://www.tiktok.com/@gilletthealth

https://twitter.com/gilletthealth

https://www.facebook.com/gilletthealth

Follow Kyle Gillett, MD

https://instagram.com/kylegillettmd

Follow James O’Hara, NP

https://Instagram.com/jamesoharanp

For 10% off Gorilla Mind products including SIGMA: Use code “GH10”

https://gorillamind.com/

For discounts on high-quality supplements

►https://www.thorne.com/u/GillettHealth

#ptsd #fda #podcast


Advertising Inquiries: https://redcircle.com/brands
Privacy & Opt-Out: https://redcircle.com/privacy
  continue reading

115 jaksoa

Kaikki jaksot

×
 
Loading …

Tervetuloa Player FM:n!

Player FM skannaa verkkoa löytääkseen korkealaatuisia podcasteja, joista voit nauttia juuri nyt. Se on paras podcast-sovellus ja toimii Androidilla, iPhonela, ja verkossa. Rekisteröidy sykronoidaksesi tilaukset laitteiden välillä.

 

Pikakäyttöopas